Rein Therapeutics, Inc. (RNTX) (CIK 0001420565) (RNTX)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Nov. 11, 2026. Latest filing activity: Apr. 28, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 28, 2026 | CORRESP | Neutral/Informational | High | Rein Therapeutics, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-1, seeking to have it declared effective by April 30, 202… | Read Filing EDGAR |
| Apr. 28, 2026 | CORRESP | Neutral/Informational | Moderate | Rein Therapeutics, Inc. has submitted a request for the acceleration of the effectiveness of their registration statement on Form S-1. The request is made by Konik Capital Partner… | Read Filing EDGAR |
| Dec. 31, 2025 | UPLOAD | Neutral/Informational | Moderate | The SEC has informed Rein Therapeutics, Inc. that it will not review their draft registration statement submitted on December 29, 2025. The SEC requests that the company publicly … | Read Filing EDGAR |